Immucor, a provider of automated instrument-reagent systems to the blood transfusion industry, has closed its previously announced acquisition of BioArray Solutions.
Subscribe to our email newsletter
Gioacchino Chirico, president and CEO of Immucor, said: “We are pleased to have completed this acquisition, which we believe will enable us to provide innovative molecular diagnostic solutions for blood transfusions to enhance patient outcomes.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.